NEXT21 K.K.
NEXT21 K.K. officially began operations in 2000 with the aim of implementing a solution business that rapidly
brings together outstanding advanced academic research and foundational industrial technologies for practical
application.
Since then, under our corporate philosophy of “developing innovative medical technologies” and “expanding
business from a global perspective,” we have been engaging in research and development through broad
collaboration with existing external organizations.
At our company, we aim to connect diverse core technologies and supply the healthcare market with
revolutionary new pharmaceuticals and medical devices that are eagerly awaited in clinical settings.
Our core business, BoneFactory, contributes to
healthcare by offering customized artificial bones (CT-Bone) and surgical 3D models tailored to each patient.
Notice
Some pages in the Research and Development section may include images or videos of efficacy verification experiments. Please be cautious when viewing such content.